Log in to save to my catalogue

Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemi...

Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2688254

Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients

About this item

Full title

Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients

Publisher

England: BioMed Central Ltd

Journal title

Arthritis research & therapy, 2009-01, Vol.11 (1), p.R22-R22, Article R22

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Anti-PM/Scl antibodies are present in sera from patients with polymyositis (PM), systemic sclerosis (SSc), and PM/SSc overlap syndromes. The prevalence of antibodies against the 75- and 100-kDa PM/Scl proteins and their clinical associations have not been studied in SSc patients in detail so far but could provide a valuable tool for risk assessment...

Alternative Titles

Full title

Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2688254

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2688254

Other Identifiers

ISSN

1478-6354

E-ISSN

1478-6354,1478-6362

DOI

10.1186/ar2614

How to access this item